Brun-Buisson C - Search Results

Year	Number of Results
1978	1
1979	1
1980	2
1981	1
1982	4
1983	5
1984	3
1985	6
1986	3
1987	10
1988	6
1989	5
1990	7
1991	5
1992	4
1993	7
1994	8
1995	7
1996	9
1997	8
1998	11
1999	12
2000	13
2001	12
2002	11
2003	14
2004	18
2005	15
2006	15
2007	13
2008	16
2009	12
2010	11
2011	22
2012	29
2013	31
2014	29
2015	26
2016	18
2017	17
2018	11
2019	13
2020	11
2021	10
2022	5
2023	2
2024	2

1

Antimicrobial Resistance as Risk Factor for Recurrent Bacteremia after Staphylococcus aureus, Escherichia coli, or Klebsiella spp. Community-Onset Bacteremia.

Abbara S, Guillemot D, Smith DRM, El Oualydy S, Kos M, Poret C, Breant S, Brun-Buisson C, Watier L. Abbara S, et al. Among authors: brun buisson c. Emerg Infect Dis. 2024 May;30(5):974-983. doi: 10.3201/eid3005.231555. Emerg Infect Dis. 2024. PMID: 38666612 Free PMC article.

2

Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.

Heming N, Renault A, Kuperminc E, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, Cariou A, Forceville X, Schwebel C, Leone M, Timsit JF, Misset B, Benali MA, Colin G, Souweine B, Asehnoune K, Mercier E, Chimot L, Charpentier C, François B, Boulain T, Petitpas F, Constantin JM, Dhonneur G, Baudin F, Combes A, Bohé J, Loriferne JF, Cook F, Slama M, Leroy O, Capellier G, Dargent A, Hissem T, Bounab R, Maxime V, Moine P, Bellissant E, Annane D; APROCCHSS investigators; CRICS-TRIGGERSEP network. Heming N, et al. Among authors: brun buisson c. Lancet Respir Med. 2024 May;12(5):366-374. doi: 10.1016/S2213-2600(23)00430-7. Epub 2024 Feb 1. Lancet Respir Med. 2024. PMID: 38310918 Clinical Trial.

3

Protocol for an international, multicentre, prospective, observational study of nosocomial pneumonia in intensive care units: the PneumoINSPIRE study.

Koulenti D, Armaganidis A, Arvaniti K, Blot S, Brun-Buisson C, Deja M, De Waele J, Du B, Dulhunty JM, Garcia-Diaz J, Judd M, Paterson DL, Putensen C, Reina R, Rello J, Restrepo MI, Roberts JA, Sjovall F, Timsit JF, Tsiodras S, Zahar JR, Zhang Y, Lipman J; Working Group on Pneumonia of the European Society of Intensive Care Medicine. Koulenti D, et al. Among authors: brun buisson c. Crit Care Resusc. 2023 Oct 18;23(1):59-66. doi: 10.51893/2021.1.OA5. eCollection 2021 Mar. Crit Care Resusc. 2023. PMID: 38046390 Free PMC article.

4

Care pathways of sepsis survivors: sequelae, mortality and use of healthcare services in France, 2015-2018.

Pandolfi F, Brun-Buisson C, Guillemot D, Watier L. Pandolfi F, et al. Among authors: brun buisson c. Crit Care. 2023 Nov 10;27(1):438. doi: 10.1186/s13054-023-04726-w. Crit Care. 2023. PMID: 37950254 Free PMC article.

5

Antimicrobial Resistance and Mortality in Hospitalized Patients with Bacteremia in the Greater Paris Area from 2016 to 2019.

Abbara S, Guillemot D, El Oualydy S, Kos M, Poret C, Breant S, Brun-Buisson C, Watier L. Abbara S, et al. Among authors: brun buisson c. Clin Epidemiol. 2022 Dec 14;14:1547-1560. doi: 10.2147/CLEP.S385555. eCollection 2022. Clin Epidemiol. 2022. PMID: 36540898 Free PMC article.

6

One-year hospital readmission for recurrent sepsis: associated risk factors and impact on 1-year mortality-a French nationwide study.

Pandolfi F, Brun-Buisson C, Guillemot D, Watier L. Pandolfi F, et al. Among authors: brun buisson c. Crit Care. 2022 Nov 29;26(1):371. doi: 10.1186/s13054-022-04212-9. Crit Care. 2022. PMID: 36447252 Free PMC article.

7

Outpatient Antibiotic Prescriptions in France: Patients and Providers Characteristics and Impact of the COVID-19 Pandemic.

Bara W, Brun-Buisson C, Coignard B, Watier L. Bara W, et al. Among authors: brun buisson c. Antibiotics (Basel). 2022 May 11;11(5):643. doi: 10.3390/antibiotics11050643. Antibiotics (Basel). 2022. PMID: 35625287 Free PMC article.

8

Trends in bacterial sepsis incidence and mortality in France between 2015 and 2019 based on National Health Data System (Système National des données de Santé (SNDS)): a retrospective observational study.

Pandolfi F, Guillemot D, Watier L, Brun-Buisson C. Pandolfi F, et al. Among authors: brun buisson c. BMJ Open. 2022 May 24;12(5):e058205. doi: 10.1136/bmjopen-2021-058205. BMJ Open. 2022. PMID: 35613798 Free PMC article.

9

From Pathophysiological Hypotheses to Case-Control Study Design: Resistance from Antibiotic Exposure in Community-Onset Infections.

Abbara S, Guillemot D, Brun-Buisson C, Watier L. Abbara S, et al. Among authors: brun buisson c. Antibiotics (Basel). 2022 Feb 4;11(2):201. doi: 10.3390/antibiotics11020201. Antibiotics (Basel). 2022. PMID: 35203803 Free PMC article.

10

The impact of non-antimicrobial drug agents on the acquisition of ESBL-producing Enterobacterales in non-critical care wards in a German university hospital: an exploratory, matched case-control study.

Klauke P, Schwab F, Gastmeier P, Maechler F; R-GNOSIS WP5 study group. Klauke P, et al. J Antimicrob Chemother. 2021 Dec 24;77(1):229-236. doi: 10.1093/jac/dkab373. J Antimicrob Chemother. 2021. PMID: 34791310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

457 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

457 results

Results by year